VAERS reports by lot

Pfizer COVID-19 lot EK9321: VAERS reports

25 VAERS reports list lot EK9321 as a Pfizer COVID-19 vaccine, received between 2020-12-24 and 2023-01-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
16%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2630%
Neurological1517%
Dermatological (non-injection-site)1012%
Gastrointestinal89%
Musculoskeletal78%
Respiratory56%
Injection-site / Local reaction56%
Cardiac / Cardiovascular45%
Psychiatric / Neuropsychiatric33%
Allergic / Anaphylactic22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 9).

Michigan3
Massachusetts3
Georgia3
Oregon2
Illinois2
Oklahoma2
Missouri2
New York1
Colorado1

Reports by month received

2020-122
2021-0115
2021-023
2021-031
2021-051
2021-061
2022-041
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.